Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry

L. Durán Graeff, D. Seidel, MJ. Vehreschild, A. Hamprecht, A. Kindo, Z. Racil, J. Demeter, S. De Hoog, U. Aurbach, M. Ziegler, H. Wisplinghoff, OA. Cornely, . ,

. 2017 ; 60 (4) : 273-279. [pub] 20170202

Language English Country Germany

Document type Case Reports, Journal Article

Persistent link   https://www.medvik.cz/link/bmc17013275

Saprochaete and Geotrichum spp. are rare emerging fungi causing invasive fungal diseases in immunosuppressed patients and scarce evidence is available for treatment decisions. Among 505 cases of rare IFD from the FungiScope(™) registry, we identified 23 cases of invasive infections caused by these fungi reported from 10 countries over a 12-year period. All cases were adults and previous chemotherapy with associated neutropenia was the most common co-morbidity. Fungaemia was confirmed in 14 (61%) cases and deep organ involvement included lungs, liver, spleen, central nervous system and kidneys. Fungi were S. capitata (n=14), S. clavata (n=5), G. candidum (n=2) and Geotrichum spp. (n=2). Susceptibility was tested in 16 (70%) isolates. All S. capitata and S. clavata isolates with the exception of one S. capitata (MIC 4 mg/L) isolate had MICs>32 mg/L for caspofungin. For micafungin and anidulafungin, MICs varied between 0.25 and >32 mg/L. One case was diagnosed postmortem, 22 patients received targeted treatment, with voriconazole as the most frequent first line drug. Overall mortality was 65% (n=15). Initial echinocandin treatment was associated with worse outcome at day 30 when compared to treatment with other antifungals (amphotericin B ± flucytosine, voriconazole, fluconazole and itraconazole) (P=.036). Echinocandins are not an option for these infections.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013275
003      
CZ-PrNML
005      
20170426114301.0
007      
ta
008      
170413s2017 gw f 000 0|eng||
009      
AR
024    7_
$a 10.1111/myc.12595 $2 doi
035    __
$a (PubMed)28150341
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a gw
100    1_
$a Durán Graeff, Luisa $u Division of Infectious Diseases, Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
245    10
$a Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry / $c L. Durán Graeff, D. Seidel, MJ. Vehreschild, A. Hamprecht, A. Kindo, Z. Racil, J. Demeter, S. De Hoog, U. Aurbach, M. Ziegler, H. Wisplinghoff, OA. Cornely, . ,
520    9_
$a Saprochaete and Geotrichum spp. are rare emerging fungi causing invasive fungal diseases in immunosuppressed patients and scarce evidence is available for treatment decisions. Among 505 cases of rare IFD from the FungiScope(™) registry, we identified 23 cases of invasive infections caused by these fungi reported from 10 countries over a 12-year period. All cases were adults and previous chemotherapy with associated neutropenia was the most common co-morbidity. Fungaemia was confirmed in 14 (61%) cases and deep organ involvement included lungs, liver, spleen, central nervous system and kidneys. Fungi were S. capitata (n=14), S. clavata (n=5), G. candidum (n=2) and Geotrichum spp. (n=2). Susceptibility was tested in 16 (70%) isolates. All S. capitata and S. clavata isolates with the exception of one S. capitata (MIC 4 mg/L) isolate had MICs>32 mg/L for caspofungin. For micafungin and anidulafungin, MICs varied between 0.25 and >32 mg/L. One case was diagnosed postmortem, 22 patients received targeted treatment, with voriconazole as the most frequent first line drug. Overall mortality was 65% (n=15). Initial echinocandin treatment was associated with worse outcome at day 30 when compared to treatment with other antifungals (amphotericin B ± flucytosine, voriconazole, fluconazole and itraconazole) (P=.036). Echinocandins are not an option for these infections.
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a amfotericin B $x farmakologie $x terapeutické užití $7 D000666
650    _2
$a antifungální látky $x farmakologie $x terapeutické užití $7 D000935
650    _2
$a echinokandiny $x farmakologie $x terapeutické užití $7 D054714
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a flukonazol $x farmakologie $x terapeutické užití $7 D015725
650    _2
$a fungemie $x diagnóza $x farmakoterapie $x mikrobiologie $7 D016469
650    _2
$a geotrichóza $x farmakoterapie $x mikrobiologie $x mortalita $7 D005847
650    _2
$a Geotrichum $x klasifikace $x účinky léků $x genetika $x izolace a purifikace $7 D005848
650    _2
$a lidé $7 D006801
650    _2
$a imunokompromitovaný pacient $7 D016867
650    _2
$a invazivní mykotické infekce $x farmakoterapie $x mikrobiologie $x mortalita $7 D000072742
650    _2
$a lipopeptidy $x farmakologie $x terapeutické užití $7 D055666
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a lidé středního věku $7 D008875
650    _2
$a neutropenie $x komplikace $x farmakoterapie $x mikrobiologie $7 D009503
650    12
$a registrace $7 D012042
650    _2
$a Saccharomycetales $x klasifikace $x účinky léků $x genetika $x izolace a purifikace $7 D004718
650    _2
$a vorikonazol $x farmakologie $x terapeutické užití $7 D065819
650    _2
$a mladý dospělý $7 D055815
655    _2
$a kazuistiky $7 D002363
655    _2
$a časopisecké články $7 D016428
700    1_
$a Seidel, Danila $u Division of Infectious Diseases, Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
700    1_
$a Vehreschild, Maria J G T $u Division of Infectious Diseases, Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany.
700    1_
$a Hamprecht, Axel $u Institute for Medical Microbiology, Immunology and Hygiene, University Hospital of Cologne, Cologne, Germany.
700    1_
$a Kindo, Anupma $u Department of Microbiology, Sri Ramachandra Medical College and Research Institute, Chennai, India.
700    1_
$a Racil, Zdenek $u Department of Internal Medicine, Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic.
700    1_
$a Demeter, Judit $u First Department of Internal Medicine, Division of Hematology, Semmelweis University, Budapest, Hungary.
700    1_
$a De Hoog, Sybren $u CBS-KNAW, Fungal Biodiversity Centre, Utrecht, Netherlands.
700    1_
$a Aurbach, Ute $u Laboratory Dr. Wisplinghoff, Cologne, Germany. $7 gn_A_00010141
700    1_
$a Ziegler, Maren $u Laboratory Dr. Wisplinghoff, Cologne, Germany.
700    1_
$a Wisplinghoff, Hilmar $u Institute for Medical Microbiology, Immunology and Hygiene, University Hospital of Cologne, Cologne, Germany. Laboratory Dr. Wisplinghoff, Cologne, Germany. Institute for Virology and Medical Microbiology, University Witten/Herdecke, Witten, Germany.
700    1_
$a Cornely, Oliver A $u Division of Infectious Diseases, Department I of Internal Medicine, University Hospital Cologne, Cologne, Germany. Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), Cologne, Germany. German Centre for Infection Research, Partner Site Bonn-Cologne, Cologne, Germany. Clinical Trials Centre Cologne, ZKS Köln, Cologne, Germany.
700    1_
$a ,
773    0_
$w MED00010272 $t Mycoses $x 1439-0507 $g Roč. 60, č. 4 (2017), s. 273-279
856    41
$u https://pubmed.ncbi.nlm.nih.gov/28150341 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20170426114619 $b ABA008
999    __
$a ok $b bmc $g 1199740 $s 974053
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2017 $b 60 $c 4 $d 273-279 $e 20170202 $i 1439-0507 $m Mycoses $n Mycoses $x MED00010272
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Archiving options